I-MAB (IMAB) Financials
IMAB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 484.7 million | 147.0 million |
2023-03-31 | 593.8 million | 155.3 million |
2022-12-31 | 591.3 million | 154.6 million |
2022-09-30 | 573.1 million | 149.9 million |
IMAB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | ? | ? |
2023-03-31 | -314.4 million | 37.4 million |
2022-12-31 | ? | ? |
2022-09-30 | ? | ? |
IMAB Net Income
No data available :(
IMAB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 406.5 million | - | 6.6 million |
2023-03-31 | 502.8 million | - | - |
2022-12-31 | 500.6 million | - | 8.1 million |
2022-09-30 | 485.3 million | - | - |
IMAB Shares Outstanding
IMAB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | - | 8.9 million | - | - |
2023-03-31 | 5.5 million | 11.6 million | 58.7 million | - |
2022-12-31 | - | - | - | - |
2022-09-30 | - | - | - | - |
IMAB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 391403 | - |
2023-03-31 | -257.2 million | 4.0 million |
2022-12-31 | - | - |
2022-09-30 | - | - |
IMAB
Price: $1.80
52 week price:
Earnings Per Share: -3.74 USD
P/E Ratio: -0.46
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 425462
Market Capitalization: 147.7 million